Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.35 extracted from

  • Khademi, M.; Bornsen, L.; Rafatnia, F.; Andersson, M.; Brundin, L.; Piehl, F.; Sellebjerg, F.; Olsson, T.
    The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers (2009), Eur. J. Neurol., 16, 528-536.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
additional information MMP-9 is decreased 12 months after natalizumab treatment in patients with relapsing-remitting multiple sclerosis Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
cerebrospinal fluid
-
Homo sapiens
-
peripheral blood mononuclear cell
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
matrix metalloproteinase-9
-
Homo sapiens
MMP-9
-
Homo sapiens